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Constrictive pericarditis presenting as 
chylothorax
Naeem M, Sobani Z A, Zubairi A, Fatmi S, Khan J A
ABSTRACT
Chylothorax is a rare clinical condition that can 
be attributed to a damaged thoracic duct. The 
condition is suggested by aspiration of milky white 
fluid from the pleural cavity and is commonly 
associated with either malignant diseases or 
trauma (e.g. cardiothoracic surgery). We present 
the case of a 15-year-old boy with chylothorax, 
whose effusion was due to constrictive pericarditis. 
The definitive treatment of chylothorax involves 
identification and management of the underlying 
pathology. We suggest that when dealing with 
cases of chylothorax, constrictive pericarditis 
should be considered among the causes.
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INTRoduCTIoN
Chylothorax is a rare clinical condition attributed to a 
damaged thoracic duct. The damage is most commonly 
associated with either malignant disease or trauma (e.g. 
cardiothoracic surgery).(1) Other reported causes include 
thrombosis of the superior vena cava or subclavian 
veins, pulmonary lymphangiomyomatosis, filariasis, 
Kaposi’s sarcoma in acquired immunodeficiency 
syndrome (AIDS), heart failure, amyloidosis, sarcoidosis, 
Behcet’s syndrome, tuberculosis (TB) and constrictive 
pericarditis.(1-4) Clinical features of chylothorax depend 
on the rate of development of effusion. Rapid effusions are 
associated with hypovolaemia and breathing difficulty, 
whereas effusion of large volumes may be associated with 
immunosuppression due to the loss of immunoglobulins 
and lymphocytes in the chyle.(5,6) 
 We present the case of a 15-year-old boy with 
treated pleural and pericardial TB leading to constrictive 
pericarditis and chylothorax.
CASe RepoRT
A 15-year-old boy with no known comorbidities 
presented to our outpatient pulmonology clinic with 
complaints of dyspnoea on exertion and persistent dry 
cough for the past three months. He had experienced 
similar symptoms associated with fever and weight 
loss three years ago. Radiological imaging revealed 
moderate left-sided pleural effusion and ascites, 
which were therapeutically drained. Analysis of the 
pleural fluid revealed protein content > 4.5 g/dL and 
a white blood cell count of 1,200 cells/ml, with 90% 
lymphocytes. Echocardiogram showed the presence 
of significant pericardial effusion. The patient was 
diagnosed with pleural/pericardial TB and started on 
a four-drug antituberculous treatment regimen for 
nine months at another centre. His symptoms as well 
as clinical and radiological findings resolved upon 
completion of the medical therapy. A year following the 
cessation of therapy, his pleural effusion returned, and 
the fluid was drained multiple times at various medical 
centres in another city. There was no fever, weight 
loss, sputum, haemoptysis, joint pain or pedal oedema 
associated with his condition, and there was no history 
of tobacco or drug use.
 The patient then presented to our department for 
an opinion regarding the cause of his recurrent pleural 
effusion. On examination, he was a lean and of average 
height. His blood pressure was 110/70 mmHg, pulse 
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Fig. 1 Anteroposterior chest radiograph on presentation shows 
moderate left-sided pleural effusion, with loss of costophrenic 
angle and heart shadow.
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was 100 beats per minute and respiratory rate was 
20 breaths per minute, while maintaining oxygen 
saturation of 97%–98% on room air. Chest examination 
revealed percussion dullness across the left middle 
and lower chest areas, with absent breath sounds. His 
jugular venous pressure was markedly elevated at 10 cm 
above the clavicle.
 Chest radiography revealed moderate left-sided 
pleural effusion (Fig. 1). Thoracocentesis of the pleural 
effusion revealed a milky white fluid (Fig. 2). Analysis 
of the pleural fluid revealed 112 mg/dL of glucose, 
1,036 mg/dL of proteins, 672 mg/dL of triglycerides 
and a total white cell count of 600 cells/ml, with 
90% lymphocytes and 10% polymorphonuclear cells. 
Microscopy was negative for bacteria after Gram and 
Ziehl Neelsen staining. Cytology was also negative 
for malignant cells. The patient’s serum triglyceride 
level was markedly raised at 672 mg/dL. The clinical 
impression indicated chylothorax. 
 Two-dimensional (2D) echocardiography revealed 
a mildly dilated right atrium and a moderately dilated 
left atrium. The left ventricular systolic function was 
normal, with an estimated ejection fraction of 55%. 
Septal bounce was also noted. The transmitral inflow 
pattern showed pseudonormalisation of left ventricular 
filling. Pulmonary vein Doppler showed prominent 
diastolic flow, which was consistent with increased 
left atrial pressure. Traces of pericardial effusion and 
thickening of the pericardium (4 mm) were also noted. 
Further investigations such as computed tomography 
were not performed, as the patient had financial 
constraints and could not afford confirmatory diagnostic 
tests. Furthermore, the 2D-echocardiography findings, 
when correlated with the clinical picture, confirmed the 
diagnosis of constrictive pericarditis.
 The patient was referred to the Department 
of Cardiothoracic Surgery for pericardiectomy. 
Histopathological examination of the pericardium 
showed fibrocollagenous and fibroadipose tissues with 
mild, chronic and nonspecific inflammation. No evidence 
of malignancy was observed. Postoperative radiograph 
of the chest showed resolution of the pericardial and 
pleural effusions. The patient was discharged following 
the removal of the chest tube, and had been under regular 
follow-up. Chest radiography at six months showed no 
signs of effusion (Fig. 3). His clinical examination at the 
12-month follow-up was unremarkable, with no recurrence 
of symptoms. He has since started playing football for his 
local team without experiencing any dyspnoea. 
dISCuSSIoN
Chylothorax is a rare clinical condition that is suggested 
by the presence of milky pleural fluid. The fluid is 
attributable to the obstruction and/or disruption of the 
thoracic duct or one of its major divisions. It has been 
proposed that elevated right-sided venous pressure in any 
context, such as dilated cardiomyopathy, severe tricuspid 
regurgitation, constrictive pericarditis and right heart 
failure, may potentially lead to chylothorax and chylous 
ascites.(7) However, the leading cause of chylothorax 
is malignancy, in particular, lymphomas and trauma, 
especially from thoracic surgery.(8) Other causes include 
sarcoidosis, amyloidosis, superior vena cava thrombosis 
and congenital duct abnormalities.(9)
 Clinical and radiological tests alone are inadequate 
for the diagnosis of chylothorax. Aspiration of milky 
pleural fluid may lead to an empirical diagnosis. 
However, this must be supported by analysis of the 
pleural fluid and identification of the disruption to the 
thoracic duct, where possible. As the fluid is derived 
from the thoracic duct, its constituents include dietary 
fat, along with immunoglobulins and leucocytes. Studies 
have reported that analysis of such aspirate should show 
a triglyceride level > 1.2 mmol/L (110 mg/dL) and white 
Fig. 2 Photograph shows milky pleural fluid being drained during 
thoracocentesis.
Fig. 3 Anteroposterior chest radiograph at the six-month follow-up 
shows clear lung fields, with no signs of recurrence or residual disease.
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blood cells (400–6,800 cells/ml), with lymphocytic 
predominance.(10) However, this is not absolute, as 
wide variations in the composition and colour of the 
chyle have been noted.(10,11) A definitive diagnosis of 
chylothorax can be established by demonstrating the 
presence of chylomicrons in the aspirated fluid.(12) 
 Our patient presented with signs of chylothorax, 
which was confirmed on aspiration of milky fluid and its 
analysis, which revealed raised levels of triglycerides. 
However, no aetiological cause could be identified. 
Nevertheless, the presence of constrictive pericarditis on 
echocardiography and the rapid resolution of chylothorax 
following pericardiectomy strongly suggested that it 
was secondary to constrictive pericarditis. Constrictive 
pericarditis rarely causes chylothorax. It has been 
postulated that chylothorax and chylous ascites in 
constrictive pericarditis are the result of increasing 
effective capillary filtration secondary to central venous 
hypertension and reduced lymphatic drainage due to high 
pressure in the left subclavian vein.(13)
 Constrictive pericarditis may occur with the 
healing of acute fibrinous, serofibrinous pericarditis 
or chronic pericardial effusion, which in turn results 
in obliteration of the pericardial cavity and formation 
of granulation tissue.(14) TB is a common cause of 
constrictive pericarditis; other causes include purulent 
infections, trauma, cardiac operation, mediastinal 
irradiation, histoplasmosis, neoplastic disease, acute viral 
or idiopathic pericarditis, rheumatoid arthritis, systemic 
lupus erythematosus and chronic renal failure treated by 
chronic dialysis.(14) The rapid resolution of our patient’s 
chylothorax following pericardiectomy strongly suggests 
that it was secondary to constrictive pericarditis. 
 Chylothorax can be treated conservatively or surgically; 
however, the definitive treatment of chylothorax is the 
identification and management of the underlying pathology. 
We suggest that when dealing with a case of chylothorax, 
constrictive pericarditis should be considered in the aetiology.
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